These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 30372683)

  • 1. Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers.
    Nasoohi S; Parveen K; Ishrat T
    J Alzheimers Dis; 2018; 66(3):857-885. PubMed ID: 30372683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin-Interacting Protein (TXNIP) Associated NLRP3 Inflammasome Activation in Human Alzheimer's Disease Brain.
    Li L; Ismael S; Nasoohi S; Sakata K; Liao FF; McDonald MP; Ishrat T
    J Alzheimers Dis; 2019; 68(1):255-265. PubMed ID: 30741672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases.
    Tsubaki H; Tooyama I; Walker DG
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes.
    Szpigel A; Hainault I; Carlier A; Venteclef N; Batto AF; Hajduch E; Bernard C; Ktorza A; Gautier JF; Ferré P; Bourron O; Foufelle F
    Diabetologia; 2018 Feb; 61(2):399-412. PubMed ID: 28988346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.
    Nasoohi S; Ismael S; Ishrat T
    Mol Neurobiol; 2018 Oct; 55(10):7900-7920. PubMed ID: 29488135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome.
    Kim DH; Kim SM; Lee B; Lee EK; Chung KW; Moon KM; An HJ; Kim KM; Yu BP; Chung HY
    J Nutr Biochem; 2017 Jul; 45():104-114. PubMed ID: 28499186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: A Focus on Insulin Resistance.
    Ezkurdia A; Ramírez MJ; Solas M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
    Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The link between iron, metabolic syndrome, and Alzheimer's disease.
    Grünblatt E; Bartl J; Riederer P
    J Neural Transm (Vienna); 2011 Mar; 118(3):371-9. PubMed ID: 20556444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance: a connecting link between Alzheimer's disease and metabolic disorder.
    Kshirsagar V; Thingore C; Juvekar A
    Metab Brain Dis; 2021 Jan; 36(1):67-83. PubMed ID: 32986168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.
    Kang S; Lee YH; Lee JE
    Yonsei Med J; 2017 May; 58(3):479-488. PubMed ID: 28332351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TXNIP contributes to induction of pro-inflammatory phenotype and caspase-3 activation in astrocytes during Alzheimer's diseases.
    Kim J; Lim J; Yoo ID; Park S; Moon JS
    Redox Biol; 2023 Jul; 63():102735. PubMed ID: 37172394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway.
    Wang S; Zhao X; Yang S; Chen B; Shi J
    Chem Biol Interact; 2017 Dec; 278():48-53. PubMed ID: 29031534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced endothelial thioredoxin-interacting protein protects arteries from damage induced by metabolic stress in vivo.
    Bedarida T; Domingues A; Baron S; Ferreira C; Vibert F; Cottart CH; Paul JL; Escriou V; Bigey P; Gaussem P; Leguillier T; Nivet-Antoine V
    FASEB J; 2018 Jun; 32(6):3108-3118. PubMed ID: 29401599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury.
    Hou Y; Wang Y; He Q; Li L; Xie H; Zhao Y; Zhao J
    Behav Brain Res; 2018 Jan; 336():32-39. PubMed ID: 28851669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention.
    Basnet R; Basnet TB; Basnet BB; Khadka S
    Curr Drug Targets; 2022; 23(7):761-767. PubMed ID: 35240955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols.
    Zhang M; Hu G; Shao N; Qin Y; Chen Q; Wang Y; Zhou P; Cai B
    Inflammopharmacology; 2021 Oct; 29(5):1317-1329. PubMed ID: 34350508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioredoxin-interacting protein: A new therapeutic target in bone metabolism disorders?
    Jiang N; Liu J; Guan C; Ma C; An J; Tang X
    Front Immunol; 2022; 13():955128. PubMed ID: 36059548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.